Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease.
Yangtong Han, Jianping Jia, Xiang-Fei Jia...
https://pubmed.ncbi.nlm.nih.gov/22503901/Actively Recruiting
Led by Capital Medical University · Updated on 2026-03-23
100000
Participants Needed
65
Research Sites
N/A
Total Duration
Researchers are conducting the China Cognition and Aging Study China COAST to understand dementia and its subtypes in China, including mild cognitive impairment MCI, sporadic and familial Alzheimers disease SAD and FAD, vascular dementia VaD, and other types. This large, national, multi-center, longitudinal observational study aims to build a comprehensive database to improve diagnosis, study the causes and genetic features, monitor disease progression, and evaluate prevention and treatment strategies, including non-drug interventions. The study also focuses on education, stigma, and management of dementia in the Chinese population. Participants include individuals with MCI, SAD, FAD, VaD, normal cognitive function, and other dementias recruited from both community and hospital populations. Researchers collect detailed demographic, clinical, genetic, imaging, and biological sample data. Study procedures include clinical evaluations, neuropsychological tests, imaging such as PETMR scans, and fluid biomarker analysis. The study follows participants through repeated assessments every 2 to 3 years, tracking changes from normal cognition to MCI and dementia, and exploring risk and protective factors. Participants engage in baseline and follow-up visits involving cognitive and mental health assessments using standardized scales like MMSE, MoCA, and CDR. Genetic analyses and biomarker measurements support diagnosis and disease understanding. The study also conducts randomized controlled trials of non-pharmacological treatments and education programs aimed at improving dementia awareness and care. Safety monitoring and informed consent are carefully managed, with ongoing follow-up to track disease progression and effects of interventions over time.
CONDITIONS
China Cognition and Aging Study
J
Jianping Jia, Doctor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Capital Medical University
Lead Sponsor
Beijing Tiantan Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline assessment
Participants undergo assessments including cognitive function tests, genetic testing, MRI scans, and biofluid sample collection to determine cognitive status and subtype classification.
1 baseline visit (in-person)
Duration - Up to 20 years
Participants are followed up every 2 to 3 years to monitor cognitive changes, biomarker levels, and disease progression through repeated evaluations and sample collections.
Follow-up visits every 2 to 3 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Have more questions? Get in touch with our team for quick support
Yangtong Han, Jianping Jia, Xiang-Fei Jia...
https://pubmed.ncbi.nlm.nih.gov/22503901/Fang Li, Xiang-Fei Jia, Jianping Jia
https://pubmed.ncbi.nlm.nih.gov/23172761/Yi Xing, Wei Qin, Fang Li...
https://pubmed.ncbi.nlm.nih.gov/22398564/Longfei Jia, Fangyu Li, Cuibai Wei...
https://pubmed.ncbi.nlm.nih.gov/33188687/Wenwen Li, Yana Pang, Yan Wang...
https://pubmed.ncbi.nlm.nih.gov/37365538/Jianping Jia, Yuye Ning, Meilin Chen...
https://pubmed.ncbi.nlm.nih.gov/38381674/Wei Qin, Xiangfei Jia, Fen Wang...
https://pubmed.ncbi.nlm.nih.gov/25690662/Aihong Zhou, Jianping Jia
https://pubmed.ncbi.nlm.nih.gov/19891819/Haiqing Song, Haixia Long, Xiumei Zuo...
https://pubmed.ncbi.nlm.nih.gov/26177270/Juexian Song, Shuying Wang, Mengshan Tan...
https://pubmed.ncbi.nlm.nih.gov/22922216/Capital Medical University
Lead Sponsor
Beijing Tiantan Hospital
Collaborating Sponsor